Piracetam: Clinical Trials

3 trials of Piracetam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Terminated 1, Withdrawn 1

Follow Piracetam: new trials by email Literature Review of Piracetam trials Research Report on Piracetam

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
Piracetam for Treatment Tardive Dyskinesia
piracetam - Tardive Dyskinesia
Phase 3CompletedBeersheva Mental Health Center402003-08-012009-11-25
A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome
L-carnitine and piracetam, Placebo - Postpoliomyelitis Syndrome
Phase 3WithdrawnBiolab Sanus Farmaceutica2015-11-17

Conditions studied

Anxiety Disorders (1)  ·  Dementia (1)  ·  Depression (1)  ·  Postpoliomyelitis Syndrome (1)  ·  Psychophysiologic Disorders (1)  ·  Schizophrenia (1)  ·  Tardive Dyskinesia (1)

Sponsors

Beersheva Mental Health Center (1)  ·  Biolab Sanus Farmaceutica (1)  ·  Hannover Medical School (1)

Countries

Brazil (1)  ·  Germany (1)  ·  Israel (1)

Top investigators

Acary Souza Bulle Oliveira, MD, PhD (1)  ·  Helge Frieling, Prof., MD (1)  ·  Igor Libov, MD (1)  ·  Vladimir Lerner, MD, PhD (1)

Results publications

PMID 17685739